Cargando…

Vaccinia Virus Expressing Interferon Regulatory Factor 3 Induces Higher Protective Immune Responses against Lethal Poxvirus Challenge in Atopic Organism

Vaccinia virus (VACV) is an enveloped DNA virus from the Orthopoxvirus family, various strains of which were used in the successful eradication campaign against smallpox. Both original and newer VACV-based replicating vaccines reveal a risk of serious complications in atopic individuals. VACV encode...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pilna, Hana, Hajkova, Vera, Knitlova, Jarmila, Liskova, Jana, Elsterova, Jana, Melkova, Zora
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8539567/ https://www.ncbi.nlm.nih.gov/pubmed/34696416 http://dx.doi.org/10.3390/v13101986

Ejemplares similares

Development of Eczema Vaccinatum in Atopic Mouse Models and Efficacy of MVA Vaccination against Lethal Poxviral Infection
por: Knitlova, Jarmila, et al.
Publicado: (2014)

Ethacrynic and α-lipoic acids inhibit vaccinia virus late gene expression
por: Spisakova, Martina, et al.
Publicado: (2009)

Oncolytic properties of non-vaccinia poxviruses
por: Ricordel, Marine, et al.
Publicado: (2018)

Immune Requirements of Post-Exposure Immunization with Modified Vaccinia Ankara of Lethally Infected Mice
por: Lauterbach, Henning, et al.
Publicado: (2010)

Monkeypox virus induces the synthesis of less dsRNA than vaccinia virus, and is more resistant to the anti-poxvirus drug, IBT, than vaccinia virus
por: Arndt, William D., et al.
Publicado: (2016)

Vaccinia Virus Shuffling: deVV5, a Novel Chimeric Poxvirus with Improved Oncolytic Potency
por: Ricordel, Marine, et al.
Publicado: (2018)

Increased Collagen Crosslinking in Stiff Clubfoot Tissue: Implications for the Improvement of Therapeutic Strategies
por: Knitlova, Jarmila, et al.
Publicado: (2021)

Protection of Rabbits and Immunodeficient Mice against Lethal Poxvirus Infections by Human Monoclonal Antibodies
por: Crickard, Lindsay, et al.
Publicado: (2012)

Comparative Analysis of Viral Gene Expression Programs during Poxvirus Infection: A Transcriptional Map of the Vaccinia and Monkeypox Genomes
por: Rubins, Kathleen H., et al.
Publicado: (2008)

Rapid Generation of Multiple Loci-Engineered Marker-free Poxvirus and Characterization of a Clinical-Grade Oncolytic Vaccinia Virus
por: Guo, Zong Sheng, et al.
Publicado: (2017)

Origin-independent plasmid replication occurs in vaccinia virus cytoplasmic factories and requires all five known poxvirus replication factors
por: De Silva, Frank S, et al.
Publicado: (2005)

Application of poxvirus K3 ortholog as a positive selection marker for constructing recombinant vaccinia viruses with modified host range
por: Cao, Jingxin, et al.
Publicado: (2020)

Poxvirus tropism
por: McFadden, Grant
Publicado: (2005)

Poxvirus Recombination
por: Evans, David Hugh
Publicado: (2022)

Zoonotic poxviruses()
por: Essbauer, Sandra, et al.
Publicado: (2010)

Protection of Mice from Lethal Vaccinia Virus Infection by Vaccinia Virus Protein Subunits with a CpG Adjuvant
por: Reeman, Sarah, et al.
Publicado: (2017)

Interferon regulatory factor 2 protects mice from lethal viral neuroinvasion
por: Li, Melody M.H., et al.
Publicado: (2016)

The Evolution of Poxvirus Vaccines
por: Sánchez-Sampedro, Lucas, et al.
Publicado: (2015)

Decoding poxvirus genome
por: Yang, Zhilong, et al.
Publicado: (2015)

ZNF598 Plays Distinct Roles in Interferon-Stimulated Gene Expression and Poxvirus Protein Synthesis
por: DiGiuseppe, Stephen, et al.
Publicado: (2018)

Poxviruses and paramyxoviruses use a conserved mechanism of STAT1 antagonism to inhibit interferon signaling
por: Talbot-Cooper, Callum, et al.
Publicado: (2022)

Interferon partly dictates a divergent transcriptional response in poxvirus-infected and bystander inflammatory monocytes
por: Melo-Silva, Carolina R., et al.
Publicado: (2022)

Activation of interferon regulatory factor 3 by replication-competent vaccinia viruses improves antitumor efficacy mediated by T cell responses
por: Riederer, Stephanie, et al.
Publicado: (2021)

The possible role of hypoxia in the affected tissue of relapsed clubfoot
por: Novotny, Tomas, et al.
Publicado: (2022)

Ability of dog owners to identify their dogs by smell
por: Přibylová, Lucie, et al.
Publicado: (2021)

Use of a Recombinant Vaccinia Virus Expressing Interferon Gamma for Post-Exposure Protection against Vaccinia and Ectromelia Viruses
por: Holechek, Susan A., et al.
Publicado: (2013)

Correlative cryo-fluorescence and cryo-scanning electron microscopy as a straightforward tool to study host-pathogen interactions
por: Strnad, Martin, et al.
Publicado: (2015)

A safer poxvirus vaccine
por: Bashyam, Hema
Publicado: (2008)

Lipid Membranes in Poxvirus Replication
por: Laliberte, Jason P., et al.
Publicado: (2010)

Detection of Infectious Poxvirus Particles
por: Nitsche, Andreas, et al.
Publicado: (2006)

Prevention of poxvirus infection by tetrapyrroles
por: Chen-Collins, Avril RM, et al.
Publicado: (2003)

NK cells and poxvirus infection
por: Burshtyn, Deborah N.
Publicado: (2013)

Poxviruses in Bats … so What?
por: Baker, Kate S., et al.
Publicado: (2014)

Suppression of Poxvirus Replication by Resveratrol
por: Cao, Shuai, et al.
Publicado: (2017)

Infections humaines à poxvirus()
por: Bohelay, G., et al.
Publicado: (2019)

Cidofovir in the treatment of poxvirus infections
por: De Clercq, Erik
Publicado: (2002)

Emergence of Salmon Gill Poxvirus
por: Tartor, Haitham, et al.
Publicado: (2022)

Chapter 15 Poxvirus infections
Publicado: (1985)

Molecular Mechanisms of Poxvirus Evolution
por: Brennan, Greg, et al.
Publicado: (2022)

Disabling complement regulatory activities of vaccinia virus complement control protein reduces vaccinia virus pathogenicity
por: Bernet, John, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_v2au9k1k9i38k138ebtlfkd9o8